Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rifampicin for Injection

Approval Number

国药准字H20244486

Company沈阳双鼎制药有限公司

Registration Date

July 30, 2024

Drug Information

Generic Name

注射用利福平

Dosage Form

注射剂

Strength

0.6g

Drug Type

化学药品

Registration Date

July 30, 2024

Company Information

Applicant Company

Company Name沈阳双鼎制药有限公司

Company Address

沈阳市浑南新区高科路15号

Manufacturing Company

Company Name沈阳双鼎制药有限公司

Company Address

沈阳高新区浑南产业区高科路15号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用利福平 - NMPA 批准文号 | MedPath